Skip to main content
AmigoFish

Monte Rosa Therapeutics announced data for MRT-8102, its NEK7-directed molecular glue degrader, showing positive impact on biomarkers linked to atherosclerotic cardiovascular disease

From BiotechTV - News · · 20 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

CEO Markus Warmuth walks us through the data and provides a broader update on the pipeline progress at Monte Rosa and for the field of degraders and molecular glues more broadly.

Back to BiotechTV - News · Report a problem